Additive melanoma suppression with intralesional phospholipid-conjugated TLR7 agonists and systemic IL-2.
about
Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responsesIL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate.Toll-like receptor agonists: a patent review (2011 - 2013).Inhibition of keratinocyte proliferation by phospholipid-conjugates of a TLR7 ligand in a Myc-induced hyperplastic actinic keratosis model in the absence of systemic side effects.Intratumoral immunotherapy for melanoma.Strategies for designing synthetic immune agonists.Structure Based Modeling of Small Molecules Binding to the TLR7 by Atomistic Level Simulations.Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer.Antitumor effect of Batf2 through IL-12 p40 up-regulation in tumor-associated macrophages.
P2860
Q30205195-9835EACA-5829-44C5-9423-196270B37B53Q35996041-2A167CFB-85D3-43E4-B6D0-49286991EEA9Q38181176-DCAC86DA-7BBE-40A3-8DD8-43FF775E78E1Q38363654-0E61E294-B307-44F3-B24F-422693597EF3Q38518518-9A53FD5C-A167-4CB9-9BCA-78CB8C7F274FQ38841677-E4CAD524-A2F2-4EE7-9052-2DEB34268256Q41719113-F8ACA624-1704-4CDD-AEBE-40143A8DC1B6Q41886564-A7C1CDF0-F877-45C9-A6F1-0700344064DEQ48240967-AAB0FA4D-FF5A-43F4-953C-58F5272C9266
P2860
Additive melanoma suppression with intralesional phospholipid-conjugated TLR7 agonists and systemic IL-2.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Additive melanoma suppression ...... R7 agonists and systemic IL-2.
@ast
Additive melanoma suppression ...... R7 agonists and systemic IL-2.
@en
Additive melanoma suppression ...... R7 agonists and systemic IL-2.
@nl
type
label
Additive melanoma suppression ...... R7 agonists and systemic IL-2.
@ast
Additive melanoma suppression ...... R7 agonists and systemic IL-2.
@en
Additive melanoma suppression ...... R7 agonists and systemic IL-2.
@nl
prefLabel
Additive melanoma suppression ...... R7 agonists and systemic IL-2.
@ast
Additive melanoma suppression ...... R7 agonists and systemic IL-2.
@en
Additive melanoma suppression ...... R7 agonists and systemic IL-2.
@nl
P2093
P2860
P1433
P1476
Additive melanoma suppression ...... R7 agonists and systemic IL-2.
@en
P2093
Christina C N Wu
Dennis A Carson
Gregory A Daniels
Howard B Cottam
John T Norton
Maripat Corr
Michael Chan
Rommel I Tawatao
Shiyin Yao
Tomoko Hayashi
P2860
P356
10.1097/CMR.0B013E328340CE6C
P407
P577
2011-02-01T00:00:00Z